Large Molecule Bioanalysis done differently

To help you achieve more.

BioAgilytix has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

usa europe labs

Advanced facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • Today Agoview on linkedin


    Immunotherapies are changing how the world treats cancer. At BioAgilytix, we are proud to support projects exploring new treatments like CAR T-cell therapy, a form of adoptive cell transfer (ACT). Our latest blog explores more about this promising therapy:

  • 1 Day Agoview on linkedin


    Join BioAgilytix’s Todd Lester this time next week at the International Conference and Exhibition on Biologics and Biosimilars, where he will be leading a presentation on NAb assay development & validation in support of biosimilar assessment. Register for the event here:

  • 1 Day Agoview on linkedin


    What is the BioAgilytix Way? It’s the differentiated approach we take to deliver premium science & service that help our customers rapidly advance their biotherapeutic innovations. See how we do it: